Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04812548
Title A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants (STIMULUS-MDS3)
Acronym STIMULUS-MDS3
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | HUN | GRC | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Novartis Investigative Site Brasschaat 2930 Belgium Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Nice 06202 France Details
Novartis Investigative Site Duesseldorf 40479 Germany Details
Novartis Investigative Site Stuttgart 70376 Germany Details
Novartis Investigative Site Alexandroupolis Evros 681 00 Greece Details
Novartis Investigative Site Patras 265 00 Greece Details
Novartis Investigative Site Nyiregyhaza 4400 Hungary Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field